Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.
Hoffmann L, Coras R, Kobow K, López-Rivera JA, Lal D, Leu C, Najm I, Nürnberg P, Herms J, Harter PN, Bien CG, Kalbhenn T, Müller M, Pieper T, Hartlieb T, Kudernatsch M, Hamer H, Brandner S, Rössler K, Blümcke I, Jabari S.
Hoffmann L, et al. Among authors: rossler k.
Acta Neuropathol. 2023 Jun;145(6):851-855. doi: 10.1007/s00401-023-02577-x.
Acta Neuropathol. 2023.
PMID: 37115209
Free PMC article.
No abstract available.